Table 6.
Sensitivity, specificity, PPV, NPV and C-statistics of QRISK3 and FRS (patients with loss to follow-up were classified as the CVD group).
Tools | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | C-statistics (95% CI) |
---|---|---|---|---|---|
QRISK3† | 59.4 | 93.6 | 96.7 | 42.6 | 0.665 (0.627, 0.704) |
FRS† | 50 | 77.6 | 73.5 | 55.5 | 0.638 (0.599, 0.677) |
QRISK3†† | 93.5 | 75.0 | 92.1 | 78.8 | 0.661(0.621, 0.700) |
FRS†† | 80.1 | 42.7 | 63.5 | 63.4 | 0.614 (0.574, 0.655) |
†Dichotomised risk scores using a cut- off of 10% 10-year CVD. †† Dichotomised risk scores using a cut-off of 20% 10-year CVD. PPV, positive predictive value; NPV, negative predictive value; C-statistics, concordance statistics; QRISK3, QRESEARCH risk estimator version 3; FRS, framingham risk score.